AzTrials
AzTrials

Dental MaterialsCerasmartNCT04995458

Clinical Evaluation of Composite-ceramic Implant-supported Posterior Crowns (Cerasmart)

A study testing composite-ceramic and Monolithic zirconia in people with Dental Materials, run by Universidad Complutense de Madrid at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The objectives of the present study are to analyze and to compare the survival rates and possible biological and technical complications arising from the use of composite-ceramic posterior implant-supported crowns with those obtained when using their counterparts prepared using monolithic zirconia restorations. Read more about this study

Who is it for?
Ages 25 to 75 years
Conditions the study is for
Dental Materials
What is being tested?
composite-ceramic and Monolithic zirconia
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteSpain
Study dates
5 Jun 2017to 20 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • One posterior tooth (molar or premolar) to restore, and with opposing tooth

Who cannot join

  • unacceptable oral hygiene
  • bruxism

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Faculty of Odontology

    Madrid, 28040

Other trials in Spain

About this study

Official title: Clinical Evaluation of Cerasmart Implant-supported Posterior Crowns

The objectives of the present study are to analyze and to compare the survival rates and possible biological and technical complications arising from the use of composite-ceramic posterior implant-supported crowns with those obtained when using their counterparts prepared using monolithic zirconia restorations. The null hypothesis is that no differences would be found between the parameters studied for each type of restoration.

Read the detailed description

Eighty patients in need of posterior implant-supported crowns (n=80) were recruited from the Master of Buccofacial Prostheses and Occlusion, Faculty of Odontology, University Complutense of Madrid, Madrid, Spain. Before treatment, all participants were informed of the purpose of the study, the clinical procedures, the material to be used, and the advantages and risks of the restorations. They were asked to give their written informed consent to participate in the study.

Eighty posterior implant-supported crowns were produced and allocated in parallel an randomly to either monolithic zirconia or composite-ceramic restorations by means of a randomization list. A total of 40 implant-supported crowns were placed using monolithic zirconia and 40 composite-ceramic. The clinical procedures were performed by two experienced clinicians. Full-arch impressions were taken using addition silicone. The restorations were cemented using a resin-based cement. The occlusion was adjusted and the surfaces polished after cementing. All restorations were prepared by an experienced technician. The restorations will be examined at one week (baseline), 1, 2, and 3 years by two researchers who were not involved in the restorative treatment. Each assessor evaluated the restoration independently, and the worst assessment will be used in the event of discrepancies.

Being tested
composite-ceramic, Monolithic zirconia
Keywords
implant-supported crowns, monolithic zirconia, composite-ceramic, clinical evaluation, survival

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • composite-ceramicProcedure or surgery

    Also called Cerasmart

    To assess the clinical performance of composite-ceramic crowns

  • Monolithic zirconiaProcedure or surgery

    To assess the clinical performance of monolithic z¡irconia crowns

Study groups in NCT04995458
Study groupRoleWhat they receive
Composite-ceramicExperimentalTo assess the clinical performance and survival of posterior composite-ceramic implant-supported crowns
Receives: Procedure: composite-ceramic
Monolithic zirconiaActive comparatorTo assess the clinical performance and survival of posterior monolitihic zirconia implant-supported crowns
Receives: Procedure: Monolithic zirconia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of restorations at baseline

    The quality of the surface and color, anatomical form and marginal integrity was assessed using the California Dental Association's (CDA) assessment system. Each CDA criterion was ranked on a scale of 1 to 4, where 4 = excellent, 3 = good, 2 = unacceptable (repair), and 1 = unacceptable (replacement).

    Measured: Baseline

  2. Quality of restorations at 1 year

    The quality of the surface and color, anatomical form and marginal integrity was assessed using the California Dental Association's (CDA) assessment system. Each CDA criterion was ranked on a scale of 1 to 4, where 4 = excellent, 3 = good, 2 = unacceptable (repair), and 1 = unacceptable (replacement).

    Measured: 1 year

  3. Quality of restorations at 2 year

    The quality of the surface and color, anatomical form and marginal integrity was assessed using the California Dental Association's (CDA) assessment system. Each CDA criterion was ranked on a scale of 1 to 4, where 4 = excellent, 3 = good, 2 = unacceptable (repair), and 1 = unacceptable (replacement).

    Measured: 2 years

  4. Quality of restorations at 3 year

    The quality of the surface and color, anatomical form and marginal integrity was assessed using the California Dental Association's (CDA) assessment system. Each CDA criterion was ranked on a scale of 1 to 4, where 4 = excellent, 3 = good, 2 = unacceptable (repair), and 1 = unacceptable (replacement).

    Measured: 3 years

  5. Plaque Index (PI) at baseline

    Plaque Index (PI) of the abutment and control teeth. A score of 0 to 3 was assigned. Higher score means a worse outcome.

    Measured: baseline

  6. Plaque Index (PI) at 1 year

    Plaque Index (PI) of the abutment and control teeth. A score of 0 to 3 was assigned. Higher score means a worse outcome.

    Measured: 1 year

  7. Plaque Index (PI) at 2 years

    Plaque Index (PI) of the abutment and control teeth. A score of 0 to 3 was assigned. Higher score means a worse outcome.

    Measured: 2 years

  8. Plaque Index (PI) at 3 years

    Plaque Index (PI) of the abutment and control teeth. A score of 0 to 3 was assigned. Higher score means a worse outcome.

    Measured: 3 years

  9. Gingival Index (GI) at baseline

    Gingival Index (GI) of the abutment and control teeth. A score of 0 to 3 was assigned. Higher score means a worse outcome.

    Measured: Baseline

  10. Gingival Index (GI) at 1 year

    Gingival Index (GI) of the abutment and control teeth. A score of 0 to 3 was assigned. Higher score means a worse outcome.

    Measured: 1 year

  11. Gingival Index (GI) at 2 years

    Gingival Index (GI) of the abutment and control teeth. A score of 0 to 3 was assigned. Higher score means a worse outcome.

    Measured: 2 years

  12. Gingival Index (GI) at 3 years

    Gingival Index (GI) of the abutment and control teeth. A score of 0 to 3 was assigned. Higher score means a worse outcome.

    Measured: 3 years

  13. Probing depth at baseline

    Probing depth of the abutment. A score of 0 to 4 was assigned. Higher score means a worse outcome

    Measured: Baseline

  14. Probing depth at 1 year

    Probing depth of the abutment. A score of 0 to 4 was assigned. Higher score means a worse outcome

    Measured: 1 year

  15. Probing depth at 2 year

    Probing depth of the abutment. A score of 0 to 4 was assigned. Higher score means a worse outcome

    Measured: 2 years

  16. Probing depth at 3 year

    Probing depth of the abutment teeth. A score of 0 to 4 was assigned. Higher score means a worse outcome

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2021
  2. Study start5 Jun 2017
  3. Primary completion20 Jul 2019
  4. Study completion20 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04995458
Sponsor's protocol ID
GC Europe N.V-4156360
Acronym
Cerasmart
Status last verified
Jan 2023
First submitted
2 Aug 2021
Last updated
25 Jan 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing composite-ceramic and Monolithic zirconia in people with Dental Materials, run by Universidad Complutense de Madrid at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of restorations at baseline (time frame: Baseline). The study lists 16 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in